Skip to content

Stephen Hoge, President at Moderna, sold MRNA on Oct 15, 2026

Data as of Oct 16

▼ SELL$8.6M39,145 shares at $220.72Stephen Hoge PresidentMRNA Moderna, Inc.
Watch MRNA
Traded
Oct 15, 2026
Disclosed
Oct 16, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Stephen Hoge, President at Moderna, sold MRNA on Oct 15, 2026TRADEDDISCLOSED
MRNASimilar stocks (XLV — its sector index fund), rebased to MRNA's price on the disclosure day
MRNA since disclosure
0.0%
after the sale
Similar stocks (XLV) since disclosure
0.0%
XLV — its sector index fund

Change in closing price from Oct 16, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLStephen Hoge PresidentMRNA Moderna, Inc.$8.3Mdisclosed Oct 16 · filed 2 days after the trade
  2. ▼ SELLStephen Hoge PresidentMRNA Moderna, Inc.$96.4Kdisclosed Oct 16 · filed 2 days after the trade

See every trade on MRNA →